Is Acomplia Rimonabant approved to be sold in the UK?
>>Click here for best price Acomplia Rimonabant medication. Prices lower than your neighborhood pharma!<<
Acomplia in UK
Acomplia is the newest weight loss drug to hit the markets in Europe. Considered to be a miracle drug for overweight patients the drug was introduced by Sanofi-Aventis of Paris.
The cannabinoid recptors are blocked by the action of the drug. The Endocannabinoid system was only recently detailed by the researchers and CB1 is one of the receptors found in that system.
It is believed that the system plays an important role in the amount of food consumed and latter the distribution of the energy produced . The surfaces of most of the cells in the body in addition to fat cells has CB1 receptors .The cells present in the brain are responsible for the appetite of the patient while the metabolic activities are taken care by the other cells present in the body . The appetite of a person increase when the CB1 receptors are stimulated by the presence of Cannabinoids.Taking this as the basic principle ,scientists at Sanofi-Aventis developed Acomplia which was able to control hunger by acting on the Cannabinoid system .
It is believed that the drug can reduce the waistlines of the patients drastically and can help in losing around 25-30 pounds. Chances of developing heart diseases are reduced when the drug is taken as it acts on the fat cells.
Acomplia has been leading the sale of weight loss drugs in UK and European Union countries countries.
Acomplia in UK
Acomplia is the newest weight loss drug to hit the markets in Europe. Considered to be a miracle drug for overweight patients the drug was introduced by Sanofi-Aventis of Paris.
The cannabinoid recptors are blocked by the action of the drug. The Endocannabinoid system was only recently detailed by the researchers and CB1 is one of the receptors found in that system.
It is believed that the system plays an important role in the amount of food consumed and latter the distribution of the energy produced . The surfaces of most of the cells in the body in addition to fat cells has CB1 receptors .The cells present in the brain are responsible for the appetite of the patient while the metabolic activities are taken care by the other cells present in the body . The appetite of a person increase when the CB1 receptors are stimulated by the presence of Cannabinoids.Taking this as the basic principle ,scientists at Sanofi-Aventis developed Acomplia which was able to control hunger by acting on the Cannabinoid system .
It is believed that the drug can reduce the waistlines of the patients drastically and can help in losing around 25-30 pounds. Chances of developing heart diseases are reduced when the drug is taken as it acts on the fat cells.
Acomplia has been leading the sale of weight loss drugs in UK and European Union countries countries.
Comments
